AECOS (American-European Congress of Ophthalmic Surgery)’s Post

Transcript

So good. Dave from Prague, the ACOs meeting the first day. My name's Arthur Cummings. I'm from Dublin, Ireland. I've got this special privilege of speaking to Professor Eden Kilich from Istanbul about the highlights of the session. We've just been in Ireland. You're very welcome. I'm very happy to talk with you, Arthur. So this was a very interesting session. We could speak about any one of the talks. Which one talk for you was the biggest information, news that might change or practice? Yes, that was amazing talk about. How is patients happiness after residual refraction, myopic or hyperopic in iOS? In iOS, and if you are very close to Emmetropia, if you target a Metropia little bit hyperopic group, residual refraction, they are more happy. What do you think about that? So it's fascinating for me whenever I wasn't on ametropia, which is most times you're not exactly 0, I would always go for the first minus, all the closest one, but that's often the first minus. But looking at the stalk. Had 45,000 patients, I think almost 90,000 eyes. It looks like we should rather be targeting slightly plus and that includes for multifocals. Yes, unbelievable. I was always choosing more little bit myopic sites. To make patients happy monofocal and multifocal. But this really I learned a lot about this session another session, another session that I really liked or lecture that I liked was the one on nearer adaptation that happens on the fly within seconds and what I took from that talk is our. The residual astigmatism may play a role and that's why patients aren't that happy afterwards if they're not, you know, corrected well, but also how they can adjust. Yeah. What did you think about that adjustment of astigmatism? Yes, is really very big issue. But I was very surprised how patients can't adapt to this new astigmatism situation. Our brain is working unbelievable and we are always as a certain focusing some rules, but patients can adapt very easily. Astigmatism and unbelievably so. And the other thing that I saw from the images that were shown of faces, if you show one face in focus and all the others are out of focus and you then go to another one where that same face has a higher focus around. Suddenly it's all relative, so it seems to be relative. So one comment from the audience was. Maybe doing bilateral simultaneous diffractive multifocals will lead to higher satisfaction because you're not comparing. Yes, I, I really, I was surprised to hear that usually I was thinking different one eye before adaptation and then second eye will be better. So many discussions is a challenge and this is wonderful evidence, something that amazing that at this stage of our careers younger than me, but we still learning all the time. It's as fascinating. And then the last one. Me, that was really interesting. I have some insight into it. You have a lot of insight is in fact allograft inlays. Maybe just share your views about allograft inlays and why you think they're very different to what we used before with the synthetic inlays for presbyopia. Yeah, actually this topic makes me very excited because I learned a lot about corneal behavior. Also in the past I had experience with scientific inlays and patient had a lot of complaints. Saturation is a question and long term results were a question. But today we change this with allograft, normal organic biologic tissue. And this this termination even makes patients happy. Ohh, this is normal tissue and they are very comfortable. As a surgeon, the most important part I am very comfortable to recommend. Why? Because this is reversible. Why? Because I don't give any damage to cornea, just flip, crash. Absolutely. You know, during the study, the other tech study four years ago is I had two patients who got very, very good outcomes from our perspective. There were N5 and they were saying well in the distance too, but they just couldn't adjust to the blended vision. And so in a very perverse way I was pleased that I could remove them. And there was no sign of any evidence of any surgery except the flap on day one and at any point afterwards, which is very different to what we did with synthetic inlays. So it is the new era and then you're also using it in pioneering work with. Allogenic inlays for keratoconus Yes, this makes me very excited because so many keratoconus patients waiting on the list for keratoplasty. If they apply earlier, they have chance to improve their vision. If they cannot use contact classes and this is young generation and they need education career. This is the best energetic period of them and to support them with safest way makes them very different level. So when I observe these things. I was very happy because in the past I used a lot of more than 1000 PMA intracorneal rim for keratoconus. I was more selective. I saw some side effects. But the most important thing than they use allograph tissue. There is same refractive index and whatever we implant to the cornea same refractive index, there is less vision quality disruption and ultimate ultimate biocompatibility. Exactly. Listen, thank you so much for giving your. View of the session also for your great contribution and for leading us in a lot of this allograph technology, so that we'd like to thank you for listening and and take care.